Târcoveanu E, Lupaşcu C, Georgescu St, Zugun Fl, Crumpei Felicia, Epure Oana, Nicorici Cristina, Canschi Gabriela, Ferariu D
Centrul de Cercetare in Chirurgie Generală Clasică si Laparoscopică, Clinica I Chirurgie "I. Tănăsescu - Vl. Buţureanu", Facultatea de Medicină, Universitatea de Medicină si Farmacie "Gr. T. Popa", Iaşi.
Rev Med Chir Soc Med Nat Iasi. 2005 Oct-Dec;109(4):770-80.
The incidence of hepatocellular carcinoma (HCC) in cirrhotic patients is increasing. Despite advances in imaging and laboratory screening which allow earlier diagnosis, the surgeon is all too often confronted with an HCC of advanced stage or arising in the setting of severe cirrhosis. Hepatic resection is still considered the treatment of choice for hepatocellular carcinoma in patients with liver cirrhosis. From 1998 to 2005, 6 patients (5 males, 1 female, age 52-70 years, mean age 64.1 years) with HCC associated severe, but well compensated liver cirrhosis (Child A-- 4 patients, Child B--2 patients) underwent 9 hepatic resection in our department. Mean tumor size was 56 mm (range 23-86 mm). Two of these lesions were in the left liver and four in the right lobe. Doppler ultrasonography was performed in all cases and CT in 3 cases to confirm the extension of the lesions. Laparoscopy was performed in 3 patients under CO2 pneumoperitoneum. The Pringle maneuver was not used. The transection of the liver parenchyma was obtained by the use of Ligasure and harmonic scalpel. Nine hepatic resections were performed: 7 segmentectomy and 2 non-anatomical resections. The resection margin was 1 cm. The mean operative time was 90 minutes (range 60-120). Mean blood loss was 250 ml and 2 patients required blood transfusion. One patient died on the tenth postoperative day from a severe respiratory distress syndrome and hepatic failure. Major morbidities occurred in three patients who developed moderate postoperative ascites, which resolved successfully with conservative treatment in two patients. Limited liver resection in cirrhotic patients with HCC is feasible with a low complication rate when careful selection criteria are followed (tumor size smaller than 8 cm, Child-Pugh A class and the good general conditions of the patients). Other medical and interventional treatments (chemoembolization, chemotherapy) can only slow the progress of HCC.
肝硬化患者中肝细胞癌(HCC)的发病率正在上升。尽管影像学和实验室筛查技术取得了进展,使得能够更早地诊断,但外科医生常常面对的是晚期HCC或在严重肝硬化背景下发生的HCC。肝切除术仍然被认为是肝硬化患者肝细胞癌的首选治疗方法。1998年至2005年,6例(5例男性,1例女性,年龄52 - 70岁,平均年龄64.1岁)伴有严重但代偿良好的肝硬化(Child A级4例,Child B级2例)的HCC患者在我科接受了9次肝切除术。平均肿瘤大小为56 mm(范围23 - 86 mm)。其中2个病灶位于左肝,4个位于右叶。所有病例均进行了多普勒超声检查,3例进行了CT检查以确认病灶范围。3例患者在二氧化碳气腹下进行了腹腔镜检查。未使用Pringle手法。肝实质的横断采用Ligasure和超声刀完成。共进行了9次肝切除术:7次节段切除术和2次非解剖性切除术。切缘为1 cm。平均手术时间为90分钟(范围60 - 120分钟)。平均失血量为250 ml,2例患者需要输血。1例患者术后第10天死于严重呼吸窘迫综合征和肝衰竭。3例患者出现了主要并发症,表现为中度术后腹水,其中2例经保守治疗成功缓解。对于符合谨慎选择标准(肿瘤大小小于8 cm、Child-Pugh A级且患者一般状况良好)的肝硬化合并HCC患者,进行有限肝切除术是可行的,且并发症发生率较低。其他医学和介入治疗(化疗栓塞、化疗)只能延缓HCC的进展。